You are currently viewing a new version of our website. To view the old version click .

Neuroprotection by Drugs, Nutraceuticals and Physical Activity, 2nd Volume

Topic Information

Dear Colleagues,

Acute and chronic neurodegenerative diseases, such as stroke, brain trauma, amyotrophic lateral sclerosis, Huntington's disease, Parkinson's disease, and Alzheimer's disease, are associated with high morbidity and mortality rates. A characteristic of these neurodegenerative diseases is selective neuronal dysfunction and death. The symptoms and the exacerbations of these diseases are, however, very different according to their specific pathways of neuronal impairment. Several mechanisms can lead to neuronal dysfunction and death, including calcium overload, excitatory amino acid release, oxidative stress, inflammation and microglial activation, protein misfolding, proteostasis and mitochondrial disfunction. The clinical management of these diseases is currently highly critical, as therapeutic strategies are often limited to relieving symptoms rather than treating the disease. Hence, the development of neuroprotective strategies to prevent or delay neuronal impairment is at the center of the current 21st-century research agenda in biomedicine. The scientific community, in addition to focusing on the development of effective new neuroprotective drugs, is also exploring non-pharmacological approaches using food components, such as nutraceuticals, and physical activity. In this regard, several studies show that nutraceuticals and physical activity have similar or complementary neuroprotection mechanisms, suggesting new integrated approaches with pharmacological interventions to enhance their neuroprotective effects. We invite you to submit your research findings to this Special Issue, which has the aim to present the updated state-of-the-art research on the potential mechanisms of neuroprotection at pre-clinical and clinical levels that are mediated by drugs, nutraceuticals and physical activity. Original research articles, review articles, clinical trials, and meta-analyses are welcome.

Dr. Cristina Angeloni
Prof. Dr. Andrea Tarozzi
Topic Editors

Keywords

  • old and new drugs
  • food supplements, nutraceuticals, and functional foods
  • physical activity and exercise
  • integrated neuroprotective interventions
  • neuroprotective mechanisms
  • neuroprotective strategies
  • new targets for neuroprotection
  • prevention of eurodegeneration
  • neurodegenerative diseases

Participating Journals

Biomedicines
Open Access
15,177 Articles
Launched in 2013
3.9Impact Factor
6.8CiteScore
17 DaysMedian Time to First Decision
Q1Highest JCR Category Ranking
Biomolecules
Open Access
12,012 Articles
Launched in 2011
4.8Impact Factor
9.2CiteScore
19 DaysMedian Time to First Decision
Q1Highest JCR Category Ranking
Current Issues in Molecular Biology
Open Access
3,395 Articles
Launched in 1999
3.0Impact Factor
3.7CiteScore
18 DaysMedian Time to First Decision
Q3Highest JCR Category Ranking
International Journal of Molecular Sciences
Open Access
104,365 Articles
Launched in 2000
4.9Impact Factor
9.0CiteScore
20 DaysMedian Time to First Decision
Q1Highest JCR Category Ranking
Pharmaceuticals
Open Access
9,580 Articles
Launched in 2004
4.8Impact Factor
7.7CiteScore
14 DaysMedian Time to First Decision
Q1Highest JCR Category Ranking

Published Papers